GLP-1 Receptor Agonists Linked to Increased Risk of Taste and Smell Changes

An analysis of electronic health records indicates a small but elevated risk of taste and smell disturbances among individuals using GLP-1 receptor agonists. These findings highlight potential adverse effects associated with this class of medications, which are commonly used for diabetes and weight management. Patients and prescribers should be aware of these possible side effects.